GoodRx Holdings, Inc. GDRX
Analyst Consensus
Price Objectif
Analyst historical
| Analyst | Entreprise | Price during analysis | Target price | Potential gain | Publication date |
|---|---|---|---|---|---|
| George Hill | Deutsche Bank | 3.47 $ | 6 $ | 2.53 % | 11/08/2025 |
| Craig Hettenbach | Morgan Stanley | 8.55 $ | 9.5 $ | 0.95 % | 10/06/2024 |
| Mark Mahaney | RBC Capital | 7.2 $ | 10 $ | 2.80 % | 23/05/2024 |
| Stephanie Davis | Barclays | 8.06 $ | 9 $ | 0.94 % | 16/05/2024 |
| Aaron Kessler | Raymond James | 7.27 $ | 10 $ | 2.73 % | 16/05/2024 |
| Scott Schoenhaus | BOCOM International Holdings Company | 6.92 $ | 9 $ | 2.08 % | 10/04/2024 |
| Scott Schoenhaus | KeyBanc | 6.74 $ | 9 $ | 2.26 % | 10/04/2024 |
| Stan Berenshteyn | Wells Fargo | 7.2262 $ | 10 $ | 2.77 % | 25/03/2024 |
| Eric Sheridan | Goldman Sachs | 4.73 $ | 3 $ | -1.73 % | 13/11/2023 |
| Steve Valiquette | Barclays | 7.76 $ | 13 $ | 5.24 % | 09/08/2022 |
| Vikram Kesavabhotla | Robert W. Baird | 7.54 $ | 7 $ | -0.54 % | 07/06/2022 |
| Stan Berenshteyn | Wells Fargo | 7.95 $ | 9 $ | 1.05 % | 12/05/2022 |
| Doug Anmuth | J.P. Morgan | 16.74 $ | 20 $ | 3.26 % | 01/03/2022 |
| Charles Rhyee | Cowen & Co. | 16.74 $ | 22 $ | 5.26 % | 01/03/2022 |
| Eric Sheridan | Goldman Sachs | 16.74 $ | 30 $ | 13.26 % | 01/03/2022 |
| George Hill | Deutsche Bank | 16.74 $ | 20 $ | 3.26 % | 01/03/2022 |
| Justin Post | Bank of America Securities | 16.74 $ | 28 $ | 11.26 % | 01/03/2022 |
| Scott Schoenhaus | Stephens | 35.83 $ | 45 $ | 9.17 % | 21/12/2021 |
| Nicholas Jones CFA | Citigroup | 30.97 $ | 53 $ | 22.03 % | 14/05/2021 |